SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SSgA Active Trust - SPDR S&P 500 ETF Trust

Amidst broad market volatility and tech sector struggles, the SPY is trending as the community debates whether this pullback signals a buying opportunity or the start of a deeper correction. Discussion revolves around potential catalysts, including the impact of economic data, Fed policy, and geopolitical events, while some traders point to technical indicators suggesting oversold conditions.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull ($BULL) is trending amid discussions around its earnings report, with community members debating whether the results justify the current stock price. Initial reactions were mixed due to some outlets initially reporting incorrect numbers. Bullish investors cite customer asset growth and potential for future gains, while others express concerns about dilution and overall market conditions.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

The Invesco QQQ Trust Series 1 ($QQQ) is experiencing high volatility as traders grapple with mixed signals and a sharp intraday reversal. Community discussions center around potential market manipulation, the impact of $NVDA's earnings, and speculation about future interest rate decisions. Some traders are anticipating a bounce, while others fear a deeper correction, creating uncertainty around the direction of the tech-heavy ETF.

Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in Boston, MA.

Ondas Holdings Inc

ONDS is trending after a significant investment in Performance Drone Works (PDW), a U.S. defense technology company specializing in AI-enabled combat robotics, as well as an $8.2M contract win. The community is discussing the potential impact of this investment on production scaling and Ondas's position in the autonomous defense sector. Despite market volatility, many express optimism about ONDS's growth potential and ability to secure further contracts.

BlackRock Institutional Trust Company N.A. - iShares Russell 2000 ETF

iShares Russell 2000 ETF

IWM is trending due to concerns about the small-cap sector's vulnerability amid fading rate cut hopes and institutional put buying, with community members closely watching key support levels and potential downside risks. Discussions revolve around whether the ETF can reclaim crucial price levels, as some traders point to technical formations suggesting further declines while others anticipate a potential oversold bounce. Overall, the conversation highlights uncertainty and a cautious outlook for small-cap performance in the near term.

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is trending as investors discuss its recent price decline and potential for a rebound ahead of upcoming earnings, with some citing market manipulation and overselling as key factors; the community is also weighing the impact of potential profitability and new partnerships on the stock's future performance amid broader concerns about the EV sector and the overall market.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology (MU) is trending amidst a broader market downturn, with community chatter focused on a recent price drop from multi-year highs. Despite positive analyst ratings and long-term growth prospects tied to AI-driven memory demand, some traders believe MU was overbought, leading to profit-taking and increased volatility. Traders are closely watching for a potential bounce and upcoming earnings data.

Walmart, Inc. engages in the retail and wholesale business. The company offers an assortment of merchandise and services at everyday low prices. It operates through the following business segments: Walmart U.S., Walmart International, and Sam's Club. The Walmart U.S. segment operates as a mass merchandiser of consumer products, operating under the Walmart and Walmart Neighborhood Market brands, including walmart.com. The Walmart International segment includes operations of wholly-owned subsidiaries in Canada, Chile, China, and Africa, and majority-owned subsidiaries in India, as well as Mexico and Central America. The Sam's Club segment manages membership-only warehouse clubs and operates samsclub.com. The company was founded by Samuel Moore Walton and James Lawrence Walton on July 2, 1962 and is headquartered in Bentonville, AR.

Walmart Inc

Walmart is trending as investors digest recent earnings, a planned move to the Nasdaq, and a CEO transition. Community members are discussing whether Walmart is a safe haven amid market uncertainty, while also weighing the impact of consumer spending trends and SNAP benefits. Some traders are analyzing technical patterns, while others are highlighting Walmart's push into e-commerce and AI.

Bitmine Immersion Technologies, Inc. is a blockchain technology company, which engages in industrial scale digital asset mining, equipment sales, and hosting operations. It operates through the Cryptocurrency Mining Industry segment. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

Bitmine Immersion Technologies Inc

BMNR is trending downwards, with community members expressing concerns about the stock's performance relative to ETH and overall crypto market conditions. Disappointment and frustration are directed towards figures like Tom Lee, with skepticism surrounding price predictions and strategic decisions. Investors are closely watching for potential earnings catalysts or staking strategy announcements that could shift momentum.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal is trending downwards, with community members expressing frustration over its continued decline despite positive earnings reports and buybacks; the stock's performance is being heavily debated relative to its peers, with some suggesting potential undervaluation while others point to leadership concerns and broader market anxieties as contributing factors. Discussions include the impact of the CEO's recent presentation, potential buyback accelerations, and comparisons to competitors in the fintech space, reflecting uncertainty about the company's future trajectory.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

VKTX Completes Enrollment in First Late-Stage Study on Obesity Drug

Viking Therapeutics completes enrollment in its phase III VANQUISH-1 obesity study, surpassing targets and marking rapid progress for its VK2735 program.

Viking Therapeutics Announces Completion of Enrollment in Phase 3 VANQUISH-1 Trial of VK2735

Viking Therapeutics Announces Completion of Enrollment in Phase 3 VANQUISH-1 Trial of VK2735 Viking Therapeutics Announces Completion of Enrollment in Phase 3 VANQUISH-1 Trial of VK2735 PR Newswire...

NVO Down 10% in 3 Months: Is This an Indication to Sell the Stock?

Novo Nordisk stock falls 10% in three months as guidance cuts, GLP-1 rivalry and looming U.S. price resets cloud growth and elevate execution risks.

Semanteon Capital Management LP Buys New Position in Viking Therapeutics, Inc. $VKTX

Semanteon Capital Management LP purchased a new position in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) in the second quarter, according to the company in its most recent 13F filing with...

Viking Therapeutics, Inc. $VKTX Shares Bought by Persistent Asset Partners Ltd

Persistent Asset Partners Ltd grew its holdings in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 88.8% in the second quarter, according to its most recent filing with the...

Can Lilly's Next-Gen Obesity Drugs Help Sustain Its Market Dominance?

Eli Lilly's next-gen obesity drugs, led by oral orforglipron and triple-acting retatrutide, aim to reshape the fast-growing weight-loss market.

Canaccord Genuity Group Issues Positive Forecast for Viking Therapeutics (NASDAQ:VKTX) Stock Price

Canaccord Genuity Group increased their price objective on shares of Viking Therapeutics from $106.00 to $107.00 and gave the stock a "buy" rating in a research report on Wednesday...

<ul class="summary-bullets"><li>Canaccord said Viking’s obesity pipeline is worth far more than the current valuation.</li><li>The Metsera outcome renewed investor focus on independent obesity-drug developers, such as Viking.</li><li>Retail traders pointed to potential Phase 3 updates and near-term catalysts.</li></ul>Viking Therapeutics shares touched a 10-month high on Wednesday after Canaccord Genuity raised its price target to $107 from $106 and kept a ‘Buy’ rating, saying the stock remains “deeply undervalued” given the value now attributed to Metsera and the more advanced nature of Viking’s obesity pipeline.Canaccord views Viking as “a highly appealing asset in the obesity space” and called it “the leading biotech asset in obesity clinical development.”<h2 class="st-heading-2">Metsera Deal Revives Focus On Independent Players</h2>The upgrade landed days after Novo Nordisk acknowledged losing its $10 billion bidding battle for obesity-drug developer Metsera to Pfizer. The outcome has intensified investor attention on standalone obesity developers, with Viking seen as one of the most strategically valuable remaining targets.<h2 class="st-heading-2">Retail Traders Reignite Deal Buzz</h2>On Stocktwits, where Viking has long been a&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/viking-therapeutics-stock-pops-to-nearly-3-month-high-as-retail-traders-intensely-speculate-on-m-and-a-scenarios/cLPIkHdRE5E">retail-driven speculation stock</a>, traders revived familiar themes.Some users floated the idea of a $15 billion to $20 billion acquisition, while others advocated for a UnitedHealth partnership or merger, arguing that it could reduce insurer costs and reshape how small-cap biotech deals are structured. Some traders said Eli Lilly may need to make a defensive offer if an insurer moves first, warning it could otherwise threaten Lilly’s obesity franchise.Other users argued Viking should stay independent, saying its obesity and MASH programs could support peak sales above $10 billion and a valuation of $50 billion or more. Several traders said the latest rally “feels different,” suggesting momentum may reflect expectations around data, partnership news, or longer-term strategic interest, noting the stock previously surged to around $90 on strong obesity-drug results.<h2 class="st-heading-2">Stocktwits Traders Eye Breakout Toward $43</h2>On Stocktwits, retail sentiment for Viking was ‘bullish’ amid ‘high’ message volume.<figure class="image"><img style="aspect-ratio:973/139;" src="https://news.stocktwits-cdn.com/vktx_ss_jpg_a3b7d43bca.webp" alt="vktx ss.jpg" width="973" height="139"><figcaption>VKTX sentiment and message volume as of November 12 | Source: Stocktwits</figcaption></figure>One user said they expected Viking shares to “lift off to $43” on Thursday, adding that they believed short volume may have been unusually high, with traders “selling small lots back and forth.”&nbsp;<stembedurl>https://stocktwits.com/NYG4ever/message/635957338</stembedurl>Another user pointed to chatter from patients and social media suggesting that screening for Viking’s Phase 3 obesity trial had wrapped up weeks earlier, saying there was a chance the company could announce completion of enrollment as soon as Thursday or sometime next week.<stembedurl>https://stocktwits.com/biolover/message/635994133</stembedurl><a href="https://stocktwits.com/symbol/VKTX">Viking’s stock</a> has risen 1.3% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a person holds a smartphone displaying the logo of Viking Therapeutics on July 19, 2025. (Photo illustration by Cheng Xin/Getty Images)

Viking Therapeutics Stock Soars To 10-Month High After Canaccord Boost – Retail Traders See It As Next Big Obesity Play

Canaccord said Viking’s obesity pipeline is worth far more than the current valuation.

Equity

Is It Worth Investing in Viking Therapeutics (VKTX) Based on Wall Street's Bullish Views?

According to the average brokerage recommendation (ABR), one should invest in Viking Therapeutics (VKTX). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Can NVO's Ozempic, Wegovy Sales Improve in 2026 After a Subdued Q3?

Novo Nordisk eyes a 2026 comeback as it slashes jobs, cuts U.S. semaglutide prices and focuses on expanding the reach of key drugs after a weak Q3.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Current Price	$34.27
Prev Close	$36.04
Open	$37.02
Dividend Yield	0.00%
50-Day Moving Average	$32.25
Beta	1.41
Avg. Volume	4.86M
PE Ratio	-17.01

52-Week High	$56.25
52-Week Low	$18.92
Market Capitalization	$4.07B
EPS (Annual)	-$1.01
Price to Book	5.68
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

VKTX
Viking Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest VKTX News

VKTXViking Therapeutics Inc